Aurinia Pharmaceuticals(AUPH) - 2025 Q4 - Earnings Call Transcript

Aurinia Pharmaceuticals (NasdaqGM:AUPH) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsGreg Keenan - Chief Medical OfficerJoe Miller - CFOPeter Greenleaf - President and CEOSahil Dhingra - Senior Equity Research AssociateWill Sawicki - AssociateConference Call ParticipantsArthur He - AnalystDavid Martin - AnalystFarzin Haque - Senior Vice President and Biotechnology Equity Research AnalystOlivia Brayer - Senior Equity AnalystOperatorGood morning. Welcome to the Aurinia Pharmaceutica ...